CRBU — Caribou Biosciences, Inc.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1619856 ·
Last close
$1.46
Market Cap
$144.80M
52W High
$2.49
52W Low
$1.43
ADV30
2,219,030
Next earnings
2026-08-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 2,397,000 | — | -26,280,000 | -25,085,000 | 148,998,000 | 12,057,000 | 46,980,000 |
| Dec 2025 | 3,941,000 | — | -28,453,000 | -26,488,000 | 175,367,000 | 12,360,000 | 53,192,000 |
| Sep 2025 | 2,198,000 | — | -29,400,000 | -27,548,000 | 194,984,000 | 11,144,000 | 53,139,000 |
| Jun 2025 | 2,667,000 | — | -35,428,000 | -54,098,000 | 220,903,000 | 25,201,000 | 54,771,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-110,992,000
Investing CF
$102,238,000
Financing CF
$4,821,000
CapEx
$-2,093,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.59
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-596,515,000
Inventory
—
Receivables
$2,979,000
ST Investments
$126,980,000
EBIT TTM
$-136,194,000
Pretax Income TTM
$-148,675,000
Interest Exp TTM
—
Analysts
7
Yahoo Snapshot (yfinance, live)
Total Revenue
$11,203,000
EBITDA
$-114,156,000
Free Cash Flow
$-63,509,124
Enterprise Value
$54,123,640
Total Cash
$117,626,000
Total Debt
$26,946,000
Shares Out
99,180,575
Trailing EPS
$-1.42
Book Value
$1.05
ROE
-83.5%
ROA
-34.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 11,159,000 | -136,194,000 | -148,125,000 | 175,367,000 | 53,192,000 | — | -110,992,000 |
| Dec 2024 | 9,994,000 | -166,616,000 | -149,105,000 | 313,313,000 | 60,362,000 | — | -138,200,000 |
| Dec 2023 | 34,477,000 | -116,059,000 | -102,070,000 | 432,209,000 | 63,808,000 | — | -93,291,000 |
| Dec 2022 | 13,851,000 | -106,399,000 | -99,421,000 | 373,765,000 | 72,894,000 | — | -90,966,000 |
TTM Snapshot
Revenues TTM
$32,966,000
NetIncome TTM
$-92,307,000
OpCashFlow TTM
$0
Assets (Latest)
$313,313,000
Forward EPS
$-1.40
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CRDL | Cardiol Therapeutics Inc. | $146.40M | $1.27 | — |
| ENTX | Entera Bio Ltd. | $147.38M | $2.99 | — |
| MOLN | MOLECULAR PARTNERS AG | $147.42M | $3.93 | — |
| IPHYF | Innate Pharma SA | $154.94M | $1.65 | — |
| ABOS | Acumen Pharmaceuticals, Inc. | $155.29M | $2.15 | — |
News headlines (Yahoo Finance, 1h cache)
BMS and Gilead rule in the CAR-T space. Off-the-shelf developers aren’t trying to change that.
2026-07-29 09:49 · Yahoo
Are Medical Stocks Lagging Caribou Biosciences (CRBU) This Year?
2026-07-09 13:40 · Yahoo
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
2026-06-29 12:00 · Yahoo
Caribou Biosciences Reports Long-Term Vispa-cel Data in Second-line Large B Cell Lymphoma at EHA 2026
2026-06-11 12:01 · Yahoo
Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting
2026-06-11 12:00 · Yahoo
Caribou Biosciences Says CRISPR CAR-T Is Pivotal-Ready, CB-011 Data Nears
2026-06-09 10:04 · Yahoo
Caribou Biosciences (CRBU) Gets A Higher Target As Confidence In Its Pipeline Grows
2026-05-31 14:38 · Yahoo
Caribou Biosciences to Participate in the 2026 Jefferies Global Healthcare Conference
2026-05-27 20:05 · Yahoo
May 2026's Promising Penny Stocks
2026-05-14 12:04 · Yahoo
Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference
2026-05-13 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.